|
19 Companies |
|
30 Products |
|
30 Products |
|
12 Mechanisms of Action |
|
3 Trials |
|
260 News |
|
| 123456» |
- ||||| everolimus / Generic mfg.
Trial completion, Enrollment change: EVERKYSTE: The Efficacy of Everolimus in Reducing Total Native Kidney Volume in Polycystic Kidney Disease Transplanted Recipients (clinicaltrials.gov) - Dec 10, 2018
P3, N=3, Completed, Sponsor: Assistance Publique - Hôpitaux de Paris
Recruiting --> Completed | N=40 --> 3
- | Trial completion, Trial completion date, Trial primary completion date: Transplant Patient Registry of Liver, Kidney and/or Pancreas (clinicaltrials.gov) - Sep 26, 2018
P=N/A, N=13767, Completed, Sponsor: Virginia Commonwealth University
Recruiting --> Completed | N=40 --> 3 Recruiting --> Completed | Trial completion date: Jan 2025 --> Aug 2018 | Trial primary completion date: Jan 2025 --> Aug 2018
- | Nebido (testosterone undecanoate depot injection) / Bayer
Trial completion date, Trial primary completion date: ALCeP: Androgen for Leydig Cell Proliferation (clinicaltrials.gov) - Sep 26, 2018
P2/3, N=56, Completed, Sponsor: University of Roma La Sapienza
Recruiting --> Completed | Trial completion date: Jan 2025 --> Aug 2018 | Trial primary completion date: Jan 2025 --> Aug 2018 Trial completion date: Oct 2014 --> Jun 2018 | Trial primary completion date: Aug 2013 --> Jun 2017
- | Growtropin-II (somatropin biosimilar) - Dong / A
Trial completion: A Clinical Study to Assess the Efficacy and Safety of DA-3002 (clinicaltrials.gov) - Jul 27, 2018
P3, N=58, Completed, Sponsor: Dong-A ST Co., Ltd.
Trial completion date: Oct 2014 --> Jun 2018 | Trial primary completion date: Aug 2013 --> Jun 2017 Active, not recruiting --> Completed
- | Trial completion: Multi-center Controlled Clinical Trials in Alport Syndrome-A Feasibility Study (clinicaltrials.gov) - Mar 22, 2018
P=N/A, N=360, Completed, Sponsor: University of Minnesota - Clinical and Translational Science Institute
Active, not recruiting --> Completed Active, not recruiting --> Completed
- | Trial completion, Enrollment change: Decision Support for Parents Receiving Information About Child's Rare Disease (clinicaltrials.gov) - Feb 20, 2018
P=N/A, N=63, Completed, Sponsor: University of Michigan
Active, not recruiting --> Completed Active, not recruiting --> Completed | N=45 --> 63
- | Sandostatin LAR Depot (octreotide acetate) / Novartis
Trial completion: ALADIN2: Somatostatin In Patients With Autosomal Dominant Polycystic Kidney Disease And Moderate To Severe Renal Insufficiency (clinicaltrials.gov) - Jan 10, 2018
P3, N=100, Completed, Sponsor: Mario Negri Institute for Pharmacological Research
Active, not recruiting --> Completed | N=45 --> 63 Active, not recruiting --> Completed
- | Trial completion, Enrollment change, Trial primary completion date: T2T@PSU: Tweens to Teens Project at Penn State (clinicaltrials.gov) - Jan 8, 2018
P=N/A, N=188, Completed, Sponsor: Penn State University
Active, not recruiting --> Completed Recruiting --> Completed | N=300 --> 188 | Trial primary completion date: Jul 2011 --> Jul 2013
- | Trial completion, Phase classification: Autosomal Dominant Polycystic Kidney Disease (ADPKD) Pain Study (clinicaltrials.gov) - Oct 20, 2017
P=N/A, N=18, Completed, Sponsor: Mayo Clinic
Recruiting --> Completed | N=300 --> 188 | Trial primary completion date: Jul 2011 --> Jul 2013 Recruiting --> Completed | Phase classification: P2 --> PN/A
- | Trial completion, Enrollment change: HYPOSPADES: Local Oestrogen Versus Placebo as Preoperative Treatment in Patients With Severe Hypospadias: Effects on Post-operative Complications (clinicaltrials.gov) - Oct 18, 2017
P3, N=244, Completed, Sponsor: Hospices Civils de Lyon
Recruiting --> Completed | Phase classification: P2 --> PN/A Active, not recruiting --> Completed | N=485 --> 244
- | Trial completion, Enrollment change: Health Needs of Patients With Kallmann Syndrome (clinicaltrials.gov) - Sep 29, 2017
P=N/A, N=249, Completed, Sponsor: Centre Hospitalier Universitaire Vaudois
Active, not recruiting --> Completed | N=485 --> 244 Active, not recruiting --> Completed | N=148 --> 249
- ||||||| Trial completion, Phase classification, Metastases: Efficacy and Safety of Tolvaptan in Subjects With Chronic Kidney Disease Between Late Stage 2 to Early Stage 4 Due to Autosomal Dominant Polycystic Kidney Disease (clinicaltrials.gov) - Sep 26, 2017
P3b, N=1370, Completed, Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Active, not recruiting --> Completed | N=148 --> 249 Active, not recruiting --> Completed | Phase classification: P3 --> P3b
- |||| Growtropin-II (somatropin biosimilar) - Dong / A
Trial primary completion date: A Clinical Study to Assess the Efficacy and Safety of DA-3002 (clinicaltrials.gov) - Sep 20, 2017
P3, N=58, Active, not recruiting, Sponsor: Dong-A ST Co., Ltd.
Active, not recruiting --> Completed | Phase classification: P3 --> P3b Trial primary completion date: Jun 2016 --> May 2018
- | Trial completion, Enrollment change, Trial primary completion date: DPNB vs. Modified DPNB With Ventromedial Infiltration (DPNB According to Dalens' Technique) (clinicaltrials.gov) - Sep 12, 2017
P=N/A, N=82, Completed, Sponsor: Claudia Spies
Trial primary completion date: Jun 2016 --> May 2018 Recruiting --> Completed | N=60 --> 82 | Trial primary completion date: Dec 2016 --> Jan 2016
- | Trial completion, Trial primary completion date: Risk of Diabetes in Young Turner Syndrome Patients (clinicaltrials.gov) - Aug 23, 2017
P=N/A, N=120, Completed, Sponsor: Children's Hospital Medical Center, Cincinnati
Recruiting --> Completed | N=60 --> 82 | Trial primary completion date: Dec 2016 --> Jan 2016 Recruiting --> Completed | Trial primary completion date: Dec 2015 --> Jun 2017
- | Trial completion, Trial primary completion date: CRISP II: Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (clinicaltrials.gov) - Aug 17, 2017
P=N/A, N=211, Completed, Sponsor: University of Pittsburgh
Recruiting --> Completed | Trial primary completion date: Dec 2015 --> Jun 2017 Enrolling by invitation --> Completed | Trial primary completion date: May 2017 --> Mar 2011
- | Sandostatin LAR Depot (octreotide acetate) / Novartis
Trial primary completion date: ALADIN2: Somatostatin In Patients With Autosomal Dominant Polycystic Kidney Disease And Moderate To Severe Renal Insufficiency (clinicaltrials.gov) - Jul 7, 2017
P3, N=98, Active, not recruiting, Sponsor: Mario Negri Institute for Pharmacological Research
Enrolling by invitation --> Completed | Trial primary completion date: May 2017 --> Mar 2011 Trial primary completion date: Jun 2017 --> Dec 2017
- | Trial completion: The Effects of Hormones in Growth Hormone-Treated Girls With Turner Syndrome (clinicaltrials.gov) - Jun 30, 2017
P2, N=80, Completed, Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Trial primary completion date: Jun 2017 --> Dec 2017 No longer recruiting --> Completed
- | Trial completion: Catecholamine Reserve and Exercise Tolerance in Healthy Volunteers and Patients With Congenital Adrenal Hyperplasia (clinicaltrials.gov) - Jun 30, 2017
P=N/A, N=61, Completed, Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
No longer recruiting --> Completed Recruiting --> Completed
- Phase classification: Short-term Renal Hemodynamic Effects of Tolvaptan in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD) (clinicaltrials.gov) - Jun 28, 2017
P2a, N=29, Completed, Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Recruiting --> Completed Phase classification: P2 --> P2a
- | Enrollment closed, Trial primary completion date: HYPOSPADES: Local Oestrogen Versus Placebo as Preoperative Treatment in Patients With Severe Hypospadias: Effects on Post-operative Complications (clinicaltrials.gov) - Jun 7, 2017
P3, N=485, Active, not recruiting, Sponsor: Hospices Civils de Lyon
Phase classification: P2 --> P2a Recruiting --> Active, not recruiting | Trial primary completion date: Jan 2018 --> Jul 2017
- | Estrace topical (estradiol) / AbbVie, Estrace (estradiol) / AbbVie
Enrollment closed, Trial primary completion date: Effects of Androgen Blockade on Sensitivity of the GnRH Pulse Generator to Suppression by Estradiol and Progesterone (clinicaltrials.gov) - Jun 1, 2017
P=N/A, N=13, Active, not recruiting, Sponsor: University of Virginia
Recruiting --> Active, not recruiting | Trial primary completion date: Jan 2018 --> Jul 2017 Completed --> Active, not recruiting | Trial primary completion date: Aug 2015 --> Aug 2018
- | Sandostatin LAR Depot (octreotide acetate) / Novartis
Trial primary completion date: ALADIN2: Somatostatin In Patients With Autosomal Dominant Polycystic Kidney Disease And Moderate To Severe Renal Insufficiency (clinicaltrials.gov) - May 9, 2017
P3, N=98, Active, not recruiting, Sponsor: Mario Negri Institute for Pharmacological Research
Completed --> Active, not recruiting | Trial primary completion date: Aug 2015 --> Aug 2018 Trial primary completion date: Mar 2017 --> Jun 2017
- ||| Enrollment change: BEYAZ-PCOS: Low Dose OC Therapy in Women With Polycystic Ovary Syndrome (PCOS): Impact of BMI on Hyperandrogenism (clinicaltrials.gov) - Mar 31, 2017
P4, N=64, Completed, Sponsor: Woman's
Trial primary completion date: Mar 2017 --> Jun 2017 N=53 --> 64
- | Enrollment change: Follicle Stimulating Hormone (FSH) to Improve Testicular Development in Men With Hypogonadism (clinicaltrials.gov) - Mar 30, 2017
P2, N=19, Terminated, Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
N=53 --> 64 N=14 --> 19
- | Trial completion, Trial primary completion date: Biomechanical Assessment of Level Gait in Patient's Status Post Bladder Exstrophy (clinicaltrials.gov) - Mar 20, 2017
P=N/A, N=6, Completed, Sponsor: Connecticut Children's Medical Center
N=14 --> 19 Recruiting --> Completed | Trial primary completion date: Apr 2012 --> Mar 2013
- | Trial completion, Enrollment change, Trial primary completion date: Micro RNAs as a Marker of Aortic Aneurysm in Hereditary Aortopathy Syndromes (clinicaltrials.gov) - Mar 15, 2017
P=N/A, N=20, Completed, Sponsor: University of Colorado, Denver
Recruiting --> Completed | Trial primary completion date: Apr 2012 --> Mar 2013 Recruiting --> Completed | N=100 --> 20 | Trial primary completion date: Oct 2016 --> Jul 2016
- ||| Trial completion: DNAAA: Clinical Implications of DNA Analysis on ADPKD (clinicaltrials.gov) - Mar 3, 2017
P=N/A, N=80, Completed, Sponsor: Kyorin University
Recruiting --> Completed | N=100 --> 20 | Trial primary completion date: Oct 2016 --> Jul 2016 Active, not recruiting --> Completed
- ||| Norditropin (somatropin) / Novo Nordisk
Trial completion, Enrollment change: Observational Prospective Study on Patients Treated With Norditropin® (clinicaltrials.gov) - Feb 6, 2017
P=N/A, N=21249, Completed, Sponsor: Novo Nordisk A/S
Active, not recruiting --> Completed Enrolling by invitation --> Completed | N=17000 --> 21249
- Trial completion: GenTAC: National Registry of Genetically Triggered Thoracic Aortic Aneurysms and Cardiovascular Conditions (clinicaltrials.gov) - Dec 20, 2016
P=N/A, N=3706, Completed, Sponsor: National Heart, Lung, and Blood Institute (NHLBI)
Enrolling by invitation --> Completed | N=17000 --> 21249 Active, not recruiting --> Completed
- Solu-Cortef (hydrocortisone sodium succinate injection) / Pfizer
Trial completion, Trial primary completion date: Comparison of Cortisol Pump With Standard Treatment for Congenital Adrenal Hyperplasia (clinicaltrials.gov) - Dec 6, 2016
P2, N=8, Completed, Sponsor: National Institutes of Health Clinical Center (CC)
Active, not recruiting --> Completed Active, not recruiting --> Completed | Trial primary completion date: Jun 2017 --> Dec 2016
- Trial completion, Enrollment change, Trial primary completion date: Uncontrolled, Open Label, Pilot and Feasibility Study of Niacinamide in Polycystic Kidney Disease (clinicaltrials.gov) - Dec 1, 2016
P2, N=10, Completed, Sponsor: Alan Yu, MB, BChir
Active, not recruiting --> Completed | Trial primary completion date: Jun 2017 --> Dec 2016 Active, not recruiting --> Completed | N=15 --> 10 | Trial primary completion date: Jun 2016 --> Feb 2016
- Trial primary completion date: CRISP II: Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (clinicaltrials.gov) - Oct 27, 2016
P=N/A, N=211, Enrolling by invitation, Sponsor: University of Pittsburgh
Active, not recruiting --> Completed | N=15 --> 10 | Trial primary completion date: Jun 2016 --> Feb 2016 Trial primary completion date: May 2016 --> May 2017
- Trial completion, Surgery: Visual Guidelines and Tutoring in Pediatric Urological Surgery (clinicaltrials.gov) - Oct 27, 2016
P=N/A, N=120, Completed, Sponsor: Shaare Zedek Medical Center
Trial primary completion date: May 2016 --> May 2017 Recruiting --> Completed
- Trial completion, Enrollment change: Subcapsular Orchiectomy in Men With Klinefelter Syndrome (clinicaltrials.gov) - Oct 4, 2016
P=N/A, N=14, Completed, Sponsor: Odense University Hospital
Recruiting --> Completed Recruiting --> Completed | N=20 --> 14
- Trial completion, Enrollment change: Diet as a Potential Treatment for Autosomal Dominant Polycystic Kidney Disease (clinicaltrials.gov) - Sep 16, 2016
P2/3, N=34, Completed, Sponsor: Tufts Medical Center
Recruiting --> Completed | N=20 --> 14 Active, not recruiting --> Completed | N=60 --> 34
- Trial completion, Enrollment change, Trial primary completion date: Pregnancy Chances in Classic Galactosemia (clinicaltrials.gov) - Sep 13, 2016
P=N/A, N=85, Completed, Sponsor: Maastricht University Medical Center
Active, not recruiting --> Completed | N=60 --> 34 Recruiting --> Completed | N=150 --> 85 | Trial primary completion date: Dec 2015 --> Sep 2016
- Trial primary completion date: Micro RNAs as a Marker of Aortic Aneurysm in Hereditary Aortopathy Syndromes (clinicaltrials.gov) - Aug 22, 2016
P=N/A, N=100, Recruiting, Sponsor: University of Colorado, Denver
Recruiting --> Completed | N=150 --> 85 | Trial primary completion date: Dec 2015 --> Sep 2016 Trial primary completion date: Jun 2016 --> Oct 2016
- Enrollment change, Trial withdrawal, Trial primary completion date: Repository Study of Autosomal Dominant Polycystic Kidney Disease (clinicaltrials.gov) - Aug 12, 2016
P=N/A, N=0, Withdrawn, Sponsor: The Rogosin Institute
Trial primary completion date: Jun 2016 --> Oct 2016 N=300 --> 0 | Recruiting --> Withdrawn | Trial primary completion date: Nov 2023 --> Jun 2016
- Enrollment closed: Decision Support for Parents Receiving Information About Child's Rare Disease (clinicaltrials.gov) - Jun 30, 2016
P=N/A, N=45, Active, not recruiting, Sponsor: University of Michigan
N=300 --> 0 | Recruiting --> Withdrawn | Trial primary completion date: Nov 2023 --> Jun 2016 Recruiting --> Active, not recruiting
- Trial completion, MRI: MRI Pilot: New Quantitive MRI Parameters in Assessing Kidneys of Autosomal Dominant Polycystic Kidney Disease (clinicaltrials.gov) - Jun 19, 2016
P=N/A, N=20, Completed, Sponsor: Mayo Clinic
Recruiting --> Active, not recruiting Recruiting --> Completed
- Trial completion, Trial primary completion date: cardiohcs: Cardiovascular Risk Profile in Patients With Congenital Adrenal Hyperplasia (clinicaltrials.gov) - Jun 18, 2016
P=N/A, N=170, Completed, Sponsor: Assistance Publique - H
Recruiting --> Completed Recruiting --> Completed | Trial primary completion date: Feb 2016 --> Sep 2015
- Trial primary completion date: Micro RNAs as a Marker of Aortic Aneurysm in Hereditary Aortopathy Syndromes (clinicaltrials.gov) - Jun 2, 2016
P=N/A, N=100, Recruiting, Sponsor: University of Colorado, Denver
Recruiting --> Completed | Trial primary completion date: Feb 2016 --> Sep 2015 Trial primary completion date: Mar 2016 --> Jun 2016
- Trial completion, Enrollment change, Trial primary completion date: Aortopathy in Persons With Bicuspid Aortic Valve, Turner and Marfan Syndrome (clinicaltrials.gov) - May 25, 2016
P=N/A, N=5, Completed, Sponsor: University of Aarhus
Trial primary completion date: Mar 2016 --> Jun 2016 Recruiting --> Completed | N=60 --> 5 | Trial primary completion date: Oct 2016 --> Oct 2015
- Trial completion, Enrollment change: X-chromosome Inactivation, Epigenetics and the Transcriptome (clinicaltrials.gov) - May 25, 2016
P=N/A, N=110, Completed, Sponsor: University of Aarhus
Recruiting --> Completed | N=60 --> 5 | Trial primary completion date: Oct 2016 --> Oct 2015 Active, not recruiting --> Completed | N=395 --> 110
- Solu-Cortef (hydrocortisone sodium succinate injection) / Pfizer
Phase classification: Comparison of Cortisol Pump With Standard Treatment for Congenital Adrenal Hyperplasia (clinicaltrials.gov) - Apr 21, 2016
P2, N=8, Active, not recruiting, Sponsor: National Institutes of Health Clinical Center (CC)
Active, not recruiting --> Completed | N=395 --> 110 Phase classification: P1/2 --> P2
- Trial completion, Trial primary completion date: Genetic Etiology in Premature Ovarian Insufficiency (clinicaltrials.gov) - Apr 18, 2016
P=N/A, N=100, Completed, Sponsor: BEGUM AYDOGAN
Phase classification: P1/2 --> P2 Recruiting --> Completed | Trial primary completion date: Nov 2015 --> Apr 2016
- Sandostatin LAR Depot (octreotide acetate) / Novartis
Trial primary completion date: ALADIN2: Somatostatin In Patients With Autosomal Dominant Polycystic Kidney Disease And Moderate To Severe Renal Insufficiency (clinicaltrials.gov) - Apr 14, 2016
P3, N=98, Active, not recruiting, Sponsor: Mario Negri Institute for Pharmacological Research
Recruiting --> Completed | Trial primary completion date: Nov 2015 --> Apr 2016 Trial primary completion date: May 2016 --> Mar 2017
- ||||| Enrollment closed, Metastases: Efficacy and Safety of Tolvaptan in Subjects With Chronic Kidney Disease Between Late Stage 2 to Early Stage 4 Due to Autosomal Dominant Polycystic Kidney Disease (clinicaltrials.gov) - Apr 1, 2016
P3, N=1371, Active, not recruiting, Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc.
Trial primary completion date: May 2016 --> Mar 2017 Recruiting --> Active, not recruiting
- || Trial primary completion date: DNAAA: Clinical Implications of DNA Analysis on ADPKD (clinicaltrials.gov) - Mar 15, 2016
P=N/A, N=80, Active, not recruiting, Sponsor: Kyorin University
Recruiting --> Active, not recruiting Trial primary completion date: Dec 2015 --> Dec 2016